Cell Therapy Technologies Market Growth Forecast With Analysis Of Industry Progress Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Cell Therapy Technologies Market During The Forecast Period?

The cell transfection market has observed robust growth in recent years. The market size is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historic period’s growth is primarily due to the expansion of molecular biology research, the increasing use of gene expression studies, the growth in recombinant protein production, the rising adoption of in vitro genetic manipulation, and the availability of diverse transfection methods.

The cell transfection market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $2.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period stems from factors such as the accelerated development of gene and cell therapies, escalating investments in genetic engineering research, an increasing need for high-throughput screening assays, the broadening scope of personalized medicine research, and the expanding adoption of non-viral delivery technologies. Key trends anticipated during the same period encompass the growing uptake of high-efficiency transfection reagents, the increasing application of viral vector-based transfection, a rising requirement for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Important Drivers Are Powering The Cell Therapy Technologies Market Growth?

The future growth of the cell transfection market is expected to be propelled by the rising number of infectious disease cases. Infectious diseases are illnesses resulting from germs that spread from one individual to another or through tainted sources. The inadequate state of public health infrastructure, alongside vaccine hesitancy and the dissemination of misinformation, has contributed to the spread and adaptation of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to examine how infections affect them and to test novel treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the escalating number of infectious disease cases drives the cell transfection market.

What Key Segment Areas Are Included In The Cell Therapy Technologies Market Assessment?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Which Trends Are Expected To Shape The Cell Therapy Technologies Market?

Major companies operating in the cell transfection market are incorporating innovations into their transfection systems to enable exact control over gene expression. A transfection system is a method or technology designed to insert foreign nucleic acids into cells to investigate gene function, synthesize proteins, or modify gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, introduced its Cellpore transfection system. This new tool is developed to improve cell engineering research. The system utilizes sophisticated microfluidic technology to facilitate the internal cellular delivery of diverse macromolecules, thereby overcoming constraints associated with conventional transfection approaches. It has the capability to transfect up to 10 million cells per second, rendering it suitable for applications requiring high throughput. The system is compatible with various cell types, including T cells and hematopoietic stem cells, and can deliver diverse cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Which Firms Are Competing In The Cell Therapy Technologies Market?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Access The Complete Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Which Region Stands As The Largest Contributor To The Cell Therapy Technologies Market?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Therapy Technologies Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Metal Structural Insulation Panels Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Exterior Insulation And Finish System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795